Astrid Weins, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Podocytes | 16 | 2024 | 403 | 2.490 |
Why?
|
Glomerulosclerosis, Focal Segmental | 13 | 2024 | 336 | 2.180 |
Why?
|
Proteinuria | 7 | 2024 | 611 | 0.970 |
Why?
|
Kidney Transplantation | 10 | 2024 | 4262 | 0.870 |
Why?
|
Actinin | 6 | 2019 | 165 | 0.870 |
Why?
|
Nephrosis, Lipoid | 3 | 2024 | 46 | 0.850 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2020 | 83 | 0.690 |
Why?
|
Kidney Diseases | 9 | 2024 | 2100 | 0.680 |
Why?
|
Autoantibodies | 3 | 2024 | 2121 | 0.660 |
Why?
|
Nephrotic Syndrome | 2 | 2024 | 381 | 0.660 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2020 | 648 | 0.570 |
Why?
|
Nephritis, Interstitial | 3 | 2023 | 158 | 0.560 |
Why?
|
Microfilament Proteins | 4 | 2007 | 1133 | 0.550 |
Why?
|
Actins | 7 | 2019 | 2064 | 0.500 |
Why?
|
Kidney Glomerulus | 7 | 2024 | 570 | 0.460 |
Why?
|
Membrane Proteins | 5 | 2024 | 7876 | 0.420 |
Why?
|
Kidney | 11 | 2024 | 7064 | 0.390 |
Why?
|
PAX2 Transcription Factor | 2 | 2024 | 86 | 0.340 |
Why?
|
Immunoglobulin kappa-Chains | 2 | 2020 | 171 | 0.330 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4568 | 0.300 |
Why?
|
Myocardium | 2 | 2020 | 4788 | 0.300 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2496 | 0.290 |
Why?
|
Cardiomyopathies | 1 | 2020 | 2056 | 0.290 |
Why?
|
Longevity | 1 | 2015 | 1077 | 0.280 |
Why?
|
Glomerulonephritis, IGA | 2 | 2024 | 61 | 0.270 |
Why?
|
TRPC Cation Channels | 2 | 2017 | 111 | 0.250 |
Why?
|
Uromodulin | 1 | 2024 | 48 | 0.240 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2023 | 41 | 0.220 |
Why?
|
Epithelial Cells | 3 | 2019 | 3703 | 0.220 |
Why?
|
Apolipoproteins A | 1 | 2023 | 96 | 0.220 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4413 | 0.210 |
Why?
|
Nephritis | 1 | 2022 | 147 | 0.190 |
Why?
|
BK Virus | 1 | 2022 | 120 | 0.190 |
Why?
|
Mice, Knockout | 8 | 2024 | 14488 | 0.190 |
Why?
|
Protein Transport | 2 | 2024 | 1951 | 0.190 |
Why?
|
Biopsy | 7 | 2024 | 6793 | 0.190 |
Why?
|
Tacrolimus | 1 | 2024 | 750 | 0.180 |
Why?
|
Polyomavirus Infections | 1 | 2022 | 192 | 0.180 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1942 | 0.180 |
Why?
|
Indenes | 1 | 2021 | 59 | 0.170 |
Why?
|
Point Mutation | 1 | 2005 | 1596 | 0.170 |
Why?
|
Lipid Peroxidation | 1 | 2021 | 276 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2022 | 437 | 0.170 |
Why?
|
Heptanes | 1 | 2019 | 8 | 0.170 |
Why?
|
Ubiquinone | 1 | 2021 | 181 | 0.170 |
Why?
|
Glomerulonephritis | 2 | 2014 | 333 | 0.160 |
Why?
|
Diabetic Nephropathies | 2 | 2024 | 973 | 0.160 |
Why?
|
Ataxia | 1 | 2021 | 307 | 0.160 |
Why?
|
Molecular Mimicry | 1 | 2019 | 213 | 0.150 |
Why?
|
Graft Rejection | 6 | 2024 | 4492 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2227 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2021 | 412 | 0.150 |
Why?
|
Receptors, Immunologic | 1 | 2024 | 1418 | 0.150 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 386 | 0.140 |
Why?
|
Hypertension, Renal | 1 | 2017 | 135 | 0.140 |
Why?
|
Doxorubicin | 1 | 2024 | 2234 | 0.140 |
Why?
|
Organoids | 2 | 2022 | 743 | 0.140 |
Why?
|
Mitochondrial Diseases | 1 | 2021 | 344 | 0.140 |
Why?
|
Cytoplasm | 1 | 2001 | 1505 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2298 | 0.140 |
Why?
|
Membrane Glycoproteins | 2 | 2024 | 3711 | 0.130 |
Why?
|
Immunosuppressive Agents | 3 | 2024 | 4206 | 0.130 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 377 | 0.130 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2024 | 2592 | 0.130 |
Why?
|
Muscle Proteins | 1 | 2001 | 1165 | 0.130 |
Why?
|
Amyloidosis | 1 | 2023 | 878 | 0.130 |
Why?
|
Immunoconjugates | 2 | 2014 | 975 | 0.130 |
Why?
|
Indazoles | 1 | 2017 | 306 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2474 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1528 | 0.120 |
Why?
|
Nanomedicine | 1 | 2017 | 292 | 0.120 |
Why?
|
Albuminuria | 2 | 2019 | 658 | 0.120 |
Why?
|
Humans | 44 | 2024 | 768166 | 0.110 |
Why?
|
Mice | 16 | 2024 | 82029 | 0.110 |
Why?
|
Phosphatidylserines | 1 | 2015 | 186 | 0.110 |
Why?
|
Glomerular Basement Membrane | 1 | 2013 | 35 | 0.110 |
Why?
|
Bone Resorption | 1 | 2018 | 728 | 0.110 |
Why?
|
Fluorocarbons | 1 | 2019 | 506 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1494 | 0.110 |
Why?
|
Pyrazoles | 2 | 2022 | 2028 | 0.110 |
Why?
|
Lysosomes | 1 | 2019 | 938 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1379 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 2909 | 0.110 |
Why?
|
Amino Acid Substitution | 2 | 2007 | 1743 | 0.110 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2013 | 84 | 0.110 |
Why?
|
Endothelial Cells | 2 | 2023 | 3589 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2013 | 193 | 0.100 |
Why?
|
Palmitic Acid | 1 | 2013 | 149 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2001 | 2885 | 0.100 |
Why?
|
Animals | 19 | 2024 | 169246 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2019 | 687 | 0.100 |
Why?
|
Male | 21 | 2024 | 364719 | 0.100 |
Why?
|
Microscopy | 1 | 2017 | 909 | 0.100 |
Why?
|
Mutation | 8 | 2024 | 30238 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8509 | 0.100 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2013 | 235 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1523 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2059 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2019 | 1887 | 0.090 |
Why?
|
Macrophages | 2 | 2024 | 5799 | 0.090 |
Why?
|
Stress Fibers | 1 | 2010 | 55 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2019 | 2451 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 826 | 0.090 |
Why?
|
Gelsolin | 1 | 2010 | 189 | 0.090 |
Why?
|
Dynamins | 1 | 2010 | 141 | 0.080 |
Why?
|
Protein Binding | 6 | 2019 | 9343 | 0.080 |
Why?
|
Mutagenesis | 2 | 2005 | 1228 | 0.080 |
Why?
|
Phagocytosis | 1 | 2015 | 1530 | 0.080 |
Why?
|
Models, Chemical | 2 | 2008 | 611 | 0.080 |
Why?
|
Consanguinity | 1 | 2011 | 460 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4648 | 0.080 |
Why?
|
Cytoskeleton | 2 | 2013 | 1179 | 0.080 |
Why?
|
Homozygote | 2 | 2011 | 1779 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 717 | 0.080 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 13421 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18349 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2021 | 4283 | 0.080 |
Why?
|
Female | 18 | 2024 | 397192 | 0.080 |
Why?
|
Binding Sites | 3 | 2008 | 6020 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 1027 | 0.080 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17622 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22379 | 0.070 |
Why?
|
HLA Antigens | 2 | 2023 | 1334 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7453 | 0.070 |
Why?
|
Pedigree | 3 | 2014 | 4539 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1319 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2007 | 3740 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2024 | 10474 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2010 | 2748 | 0.070 |
Why?
|
Adult | 9 | 2024 | 223646 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9538 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2954 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6231 | 0.060 |
Why?
|
Apoptosis | 2 | 2024 | 9523 | 0.060 |
Why?
|
Fibroblasts | 1 | 2015 | 4176 | 0.060 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2017 | 246 | 0.060 |
Why?
|
Models, Molecular | 3 | 2014 | 5403 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1754 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 41754 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1683 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2020 | 2560 | 0.060 |
Why?
|
Disease Progression | 3 | 2018 | 13671 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3228 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 3772 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 18065 | 0.050 |
Why?
|
Graft Survival | 2 | 2024 | 3887 | 0.050 |
Why?
|
Focal Adhesions | 1 | 2023 | 113 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
HLA-DQ Antigens | 1 | 2023 | 190 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Child, Preschool | 2 | 2024 | 42669 | 0.050 |
Why?
|
Middle Aged | 8 | 2024 | 223492 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2007 | 1191 | 0.050 |
Why?
|
Thiazolidines | 1 | 2001 | 70 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2001 | 78 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2022 | 189 | 0.050 |
Why?
|
Janus Kinases | 1 | 2022 | 253 | 0.050 |
Why?
|
Heating | 1 | 2001 | 104 | 0.050 |
Why?
|
Azetidines | 1 | 2022 | 152 | 0.050 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2021 | 89 | 0.040 |
Why?
|
Static Electricity | 2 | 2014 | 260 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2001 | 179 | 0.040 |
Why?
|
Lupus Nephritis | 1 | 2024 | 327 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9015 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2479 | 0.040 |
Why?
|
Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
Fibronectins | 1 | 2023 | 722 | 0.040 |
Why?
|
Kinetics | 1 | 2007 | 6329 | 0.040 |
Why?
|
Child | 4 | 2024 | 80917 | 0.040 |
Why?
|
Activating Transcription Factor 6 | 1 | 2019 | 31 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1670 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2013 | 19015 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4786 | 0.040 |
Why?
|
Isoantibodies | 1 | 2023 | 681 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2001 | 838 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15832 | 0.040 |
Why?
|
Purines | 1 | 2022 | 615 | 0.040 |
Why?
|
Crystallization | 1 | 2019 | 520 | 0.040 |
Why?
|
Hypokalemia | 1 | 2019 | 152 | 0.040 |
Why?
|
Sulfonamides | 2 | 2022 | 1982 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1441 | 0.040 |
Why?
|
Adenoviridae | 1 | 2022 | 1092 | 0.040 |
Why?
|
Rats, Inbred Dahl | 1 | 2017 | 34 | 0.040 |
Why?
|
Rats, Transgenic | 1 | 2017 | 70 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 403 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13586 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 376 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2001 | 931 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2019 | 392 | 0.040 |
Why?
|
Calcification, Physiologic | 1 | 2018 | 170 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2019 | 239 | 0.040 |
Why?
|
Histological Techniques | 1 | 2017 | 194 | 0.030 |
Why?
|
Paraproteinemias | 1 | 2019 | 252 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15597 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3428 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 788 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6082 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2065 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.030 |
Why?
|
Models, Biological | 2 | 2013 | 9495 | 0.030 |
Why?
|
Regeneration | 1 | 2024 | 1524 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59629 | 0.030 |
Why?
|
Mucin-1 | 1 | 2019 | 537 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3160 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1542 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2001 | 1408 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10873 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1918 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16726 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2227 | 0.030 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2013 | 40 | 0.030 |
Why?
|
Protamines | 1 | 2013 | 112 | 0.030 |
Why?
|
Protein Conformation | 2 | 2014 | 3956 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2013 | 82 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2019 | 11669 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11928 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2013 | 120 | 0.030 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2013 | 190 | 0.030 |
Why?
|
Genetic Testing | 1 | 2005 | 3591 | 0.030 |
Why?
|
Protective Agents | 1 | 2013 | 150 | 0.020 |
Why?
|
Benzylamines | 1 | 2013 | 251 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 742 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9561 | 0.020 |
Why?
|
Dexamethasone | 1 | 2019 | 1965 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2018 | 873 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4978 | 0.020 |
Why?
|
Benzoates | 1 | 2013 | 213 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2393 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8741 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2018 | 1804 | 0.020 |
Why?
|
Urogenital Abnormalities | 1 | 2014 | 255 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 13045 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1813 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1162 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171504 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2832 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11095 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14729 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2014 | 433 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1805 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6316 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2232 | 0.020 |
Why?
|
Rats | 2 | 2017 | 23760 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 737 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20227 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7598 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1606 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8317 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3610 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1976 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2540 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1009 | 0.020 |
Why?
|
Neuropeptides | 1 | 2013 | 951 | 0.020 |
Why?
|
Cell Death | 1 | 2013 | 1679 | 0.020 |
Why?
|
Computer Simulation | 2 | 2014 | 6283 | 0.020 |
Why?
|
Viscosity | 1 | 2008 | 334 | 0.020 |
Why?
|
Ultracentrifugation | 1 | 2007 | 182 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5926 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2227 | 0.020 |
Why?
|
Incidence | 1 | 2005 | 21538 | 0.020 |
Why?
|
X-Ray Diffraction | 1 | 2007 | 416 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3590 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1505 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3347 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2001 | 12800 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 656 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5330 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3628 | 0.020 |
Why?
|
Endocytosis | 1 | 2010 | 956 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23645 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2219 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54926 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 65371 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4120 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2464 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4146 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 1216 | 0.010 |
Why?
|
Monocytes | 1 | 2014 | 2605 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3074 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13014 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4772 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81762 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12795 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2257 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 1951 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12421 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1083 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3603 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10101 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11878 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2798 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 89169 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17140 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 60066 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13676 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 16045 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39348 | 0.010 |
Why?
|